Fedbank Financial shares slip as True North exits via block deal; Check buyer in the deal
As of March 31, 2026, True North Fund VI LLP held a 7.26% stake in the company, amounting to 2.72 crore shares.
Latest News
SBI plans to raise up to $2 billion via overseas bonds in FY27
The bank stated that the plan is subject to market conditions and regulatory approvals as applicable.
Ethos Q4 Results: Revenue jumps 33%; profitability remains under pressure
Ethos reported healthy revenue growth in the March quarter, driven by continued demand, although margin pressure and slower operating profit growth weighed on overall profitability…
New SIP registrations fall to 12-month low as closures outpace additions for second straight month
Around 50.71 lakh new SIPs were registered during April — the lowest monthly addition in the past 12 months — while 51.29 lakh SIPs were…
Kaynes Tech shares fall 9% in two sessions ahead of Q4 results on Wednesday
The 53% topline growth during the quarter for Kaynes is likely to be driven by a combination of smart meters, electric vehicles and the auto…
Pine Labs enters Philippines market with GCash partnership
Pine Labs partners with GCash for Business to expand digital payments for MSMEs in the Philippines, integrating POS tech and IPP offers, shares down 2%…
Dixon Tech Q4 Results: Softer smartphone volumes to impact topline, margins may narrow
Weakness in Xiaomi and Ismartu volumes could also hurt Dixon’s mobile business this quarter. Higher memory prices, tight availability of DRAM is likely to have…
Gold, silver rise in India today: Here’s why Tata MF sees support building despite volatility
Gold and silver prices rise on MCX. Tata Asset Management sees near term volatility but maintains a bullish long term outlook for precious metals.
Invasset PMS’ Anirudh Garg sees power stocks leading market recovery, avoids IT and lenders
Crude prices, rupee pressure and FII selling remain key concerns for equities, according to Invasset PMS’ Anirudh Garg. He expects mid- and smallcap stocks to…
Corona Remedies shares fall 3% despite 44% jump in Q4 profit; margins contract
Corona Remedies shares fell over 3% despite strong Q4FY26 and FY26 revenue and profit growth, margin pressure, acquisitions, capacity expansion and EAEU-GMP certification.